Glyrova CV 20 Tablet

Glyrova CV 20 Tablet is a combination drug composed of a blood-thinning agent and cholesterol-lowering agent, primarily used to prevent heart attack and stroke in the future. It lowers the raised level of cholesterol and fats (triglycerides) in our body. A heart attack is a condition in which your coronary arteries (blood vessel supplying blood and oxygen to the heart) becomes blocked due to build-up of fats (plaque) including cholesterol. These plaques narrow the arteries, leading to atherosclerosis and coronary artery disease, mainly for most heart attacks.

Glyrova CV 20 Tablet is composed of two medicines, namely: Rosuvastatin and Clopidogrel. Rosuvastatin is a lipid-lowering medication that blocks the enzyme required to make cholesterol in the body. As a result, it lowers the bad cholesterol (low-density lipoproteins or LDL), triglycerides (TG) and increases the levels of good cholesterol (high-density lipoproteins or HDL). Clopidogrel is a blood thinner (anticoagulant) that collectively prevents a clot in the blood vessels. Together Glyrova CV 20 Tablet reduces the increased levels of bad cholesterol (low-density lipoprotein and triglycerides) and prevents blood clots, thereby reducing and preventing the risk of heart attack, stroke and heart-related chest pain (angina).

Take Glyrova CV 20 Tablet exactly as directed by your doctor. The dose and duration of Glyrova CV 20 Tablet may differ depending on the reason why you're taking it and your responses to treatment. In some cases, you may experience headaches, ankle swelling due to fluid retention (oedema), slow heart rate, and nausea. Glyrova CV 20 Tablet is known to cause dizziness, so driving should be avoided. Most of these side effects of Glyrova CV 20 Tablet do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor.

Try not to stop taking Glyrova CV 20 Tablet of your own. Suddenly stopping Glyrova CV 20 Tablet may worsen your condition and increase your risk of a future heart attack. Inform your doctor know if you are allergic to rosuvastatin, clopidogrel, or have any active liver disease (liver enzymes abnormalities), active bleeding issues (like peptic ulcer, brain haemorrhage), or muscle problem (myopathy, rhabdomyolysis). The patient should inform the doctor that they are taking Glyrova CV 20 Tablet before any surgery is scheduled or any new medicine is taken. Rosuvastatin present in Glyrova CV 20 Tablet is a pregnancy category X drug, so it should not be given to pregnant women. It may cause harm to the fetus if administered to pregnant or breastfeeding women.

Rosuvastatin is a lipid-lowering medication that blocks the enzyme required to make cholesterol in the body. As a result, it lowers the bad cholesterol (low-density lipoproteins or LDL), triglycerides (TG) and increases the levels of good cholesterol (high-density lipoproteins or HDL). Clopidogrel is a blood thinner (anticoagulant) that collectively prevents a clot in the blood vessels. Together Glyrova CV 20 Tablet reduces the increased levels of bad cholesterol (low-density lipoprotein and triglycerides) and prevents blood clots, thereby reducing the risk of heart attack, stroke, and heart-related chest pain (angina).

Tell your doctor if you are allergic to rosuvastatin, clopidogrel, or any of its ingredients. If you have any active liver disease, active bleeding issues (like peptic ulcers, brain haemorrhage), pregnant, or plan to become pregnant or breastfeeding, do not take Glyrova CV 20 Tablet until prescribed. The patient should inform the doctor that they are taking Glyrova CV 20 Tablet before any surgery is scheduled or any new medicine is taken. Rosuvastatin present in Glyrova CV 20 Tablet is a pregnancy category X drug, so it is contraindicated in pregnant women. As it may cause harm to the fetus if administered to pregnant women. The risk of muscle problems might increase if Glyrova CV 20 Tablet is taken with an antibiotic (clarithromycin), anti-HIV drugs (ritonavir, lopinavir, darunavir, atazanavir, indinavir) and antifungal (itraconazole). Coadministration with anticoagulants like warfarin may cause gastric bleeding and other bleeding problems. So, if you are using any blood-thinning agents, let your doctor know about this. Glyrova CV 20 Tablet contains rosuvastatin, which can cause muscle problems like myopathy and rhabdomyolysis. Patients with active liver disease should use the Glyrova CV 20 Tablet with caution. Safety and effectiveness of Glyrova CV 20 Tablet have not been established, so its use should be avoided in paediatric patients less than ten years of age. Discontinuation of Glyrova CV 20 Tablet may lead to cardiovascular events like heart attack, stroke, and angina (heart-related chest pain). Hence, you should consult a doctor before stopping the dose of Glyrova CV 20 Tablet .